Age dependency of the cariporide-mediated cardio-protection after simulated ischemia in isolated human atrial heart muscles

Experimental Gerontology

Volumn 43, Issue 7, 2008, Pages 691-699

  Simm, Andreas ^a   Friedrich, Ivar ^a   Scheubel, Robert J ^a   Gursinsky, Torsten ^a   Silber, Rolf Edgar ^a   Bartling, Babett ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Aging; Cariporide; Ischemia; Myocardium; NHE1

Indexed keywords

CARIPORIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM PROTON EXCHANGE PROTEIN 1;

ADULT; AGE; AGED; AGING; ANGINA PECTORIS; ARTICLE; CELL STRESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART ATRIUM MUSCLE; HEART MUSCLE; HEART PROTECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MUSCLE ISCHEMIA; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; CATION TRANSPORT PROTEINS; DRUG EVALUATION, PRECLINICAL; GUANIDINES; HEART; HEART ATRIA; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; ORGAN CULTURE TECHNIQUES; SODIUM-HYDROGEN ANTIPORTER; SULFONES;

ANGINA;

EID: 46749143235     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.04.017     Document Type: Article

References (40)

1. i and contractility during ischemia and reperfusion. Circulation 86 (1992) II371-II376
2. Ausma J., Thone F., Dispersyn G.D., Flameng W., Vanoverschelde J.L., Ramaekers F.C., and Borgers M. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol. Cell. Biochem. 186 (1998) 159-168
3. Avkiran M., and Marber M. Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J. Am. Coll. Cardiol. 39 (2002) 747-753
4. Bartling B., Friedrich I., Silber R., and Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann. Thorac. Surg. 76 (2003) 105-111
5. Besse S., Tanguy S., Boucher F., Huraux C., Riou B., Swynghedauw B., and de Leiris J. Protection of endothelial-derived vasorelaxation with cariporide, a sodium-proton exchanger inhibitor, after prolonged hypoxia and hypoxia-reoxygenation: effect of age. Eur. J. Pharmacol. 531 (2006) 187-193
6. Besse S., Tanguy S., Boucher F., Le Page C., Rozenberg S., Riou B., Leiris J., and Swynghedauw B. Cardioprotection with cariporide, a sodium-proton exchanger inhibitor, after prolonged ischemia and reperfusion in senescent rats. Exp. Gerontol. 39 (2004) 1307-1314
7. Boengler K., Konietzka I., Buechert A., Heinen Y., Garcia-Dorado D., Heusch G., and Schulz R. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1764-H1769
8. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79 (1999) 609-634
9. Cain B., Meldrum D., Joo K., Wang J.F., Meng X., Cleveland J., Banerjee A., and Harken A. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J. Am. Coll. Cardiol. 32 (1998) 458-467
10. Corbett R., Laptook A., Gee J., Garcia D., Silmon S., and Tollefsbol G. Age-related differences in the effect of dichloroacetate on postischemic lactate and acid clearance measured in vivo using magnetic resonance spectroscopy and microdialysis. J. Neurochem. 71 (1998) 1205-1214
11. Ebrahim Z., Yellon D.M., and Baxter G.F. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp. Gerontol. 42 (2007) 807-814
12. Fantinelli J.C., Cingolani H.E., and Mosca S.M. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species. Cardiovasc. Pathol. 15 (2006) 179-184
13. + exchanger. Mol. Cell. Biochem. 125 (1993) 137-143
14. Ghosh S., Standen N.B., and Galinanes M. Preconditioning the human myocardium by simulated ischemia studies on the early and delayed protection. Cardiovasc. Res. 45 (2000) 339-350
15. Goldberg R.J., Gore J.M., Gurwitz J.H., Alpert J.S., Brady P., Strohsnitter W., Chen Z.Y., and Dalen J.E. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am. Heart J. 117 (1989) 543-549
16. + exchange inhibition improve reperfusion ion homeostasis. Ann. Thorac. Surg. 73 (2002) 569-574
17. + exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation 100 (1999) 2519-2526
18. Gumina R., Terzic A., and Gross G. Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism?. Basic Res. Cardiol. 96 (2001) 319-324
19. +-overload in ischemia and is cardio-protective. J. Mol. Cell. Cardiol. 31 (1999) 1985-1995
20. 2 delivery. J. Appl. Physiol. 94 (2003) 744-751
21. Hirose H., Amano A., Yoshida S., Takahashi A., Nagano N., and Kohmoto T. Coronary artery bypass grafting in the elderly. Chest 117 (2000) 1262-1270
22. Horvath K., DiSesa V., Peigh P., Couper G., Collins J.J., and Cohn L. Favorable results of coronary artery bypass grafting in patients older than 75 years. J. Thorac. Cardiovasc. Surg. 99 (1990) 92-96
23. + exchanger and ischemia-reperfusion injury in the myocardium. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2237-H2247
24. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
25. + exchange: structure, regulation, and its role in heart disease. Circ. Res. 85 (1999) 777-786
26. Lakatta E., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107 (2003) 346-354
27. Lin H., and Suleiman M. Cariporide enhances lactate clearance upon reperfusion but does not alter lactate accumulation during global ischaemia. Pflugers Arch. 447 (2003) 8-13
28. Loubani M., Ghosh S., and Galinanes M. The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning. J. Thorac. Cardiovasc. Surg. 126 (2003) 143-147
29. Mariani J., Ou R., Bailey M., Rowland M., Nagley P., Rosenfeldt F., and Pepe S. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J. Thorac. Cardiovasc. Surg. 120 (2000) 660-667
30. Nakai Y., Horimoto H., Mieno S., and Sasaki S. Na(+)/H(+) exchanger inhibitor HOE642 offers myoprotection in senescent myocardium independent of ischemic preconditioning mechanisms. Eur. Surg. Res. 34 (2002) 244-250
31. Roques F., Nashef S., Michel P., Gauducheau E., de Vincentiis C., Baudet E., Cortina J., David M., Faichney A., Gabrielle F., Gams E., Harjula A., Jones M., Pintor P., Salamon R., and Thulin L. Risk factors and outcome in European cardiac surgery analysis of the EuroSCORE multinational database of 19030 patients. Eur. J. Cardiothorac. Surg. 15 (1999) 816-822
32. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 101 (2000) 2902-2908
33. 2+-ATPase. Circulation 101 (2000) 790-796
34. + exchanger isoform 1 (NHE1) in non-infarcted myocardium after acute myocardial infarction. Jpn. Heart J. 43 (2002) 273-282
35. 2+ overload and prolonged acidosis on reperfusion. Circulation 101 (2000) 2749-2755
36. Tani M., Suganuma Y., Hasegawa H., Shinmura K., Hayashi Y., Guo X., and Nakamura Y. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 95 (1997) 2559-2566
37. Theroux P., Chaitman B., Danchin N., Erhardt L., Meinertz T., Schroeder J., Tognoni G., White H., Willerson J., and Jessel A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) investigators. Circulation 102 (2000) 3032-3038
38. Wennberg D., Makenka D., Sengupta A., Lucas F., Vaitkus P., Quinton H., O'Rourke D., Robb J., Kellett M.J., Shubrooks S.J., Bradley W.A., Hearne M., Lee P., and O'Connor G. Percutaneous transluminal coronary angioplasty in the elderly: epidemiology clinical risk factors and in-hospital outcomes. Am. Heart J. 137 (1999) 639-645
39. + exchanger activity and expression in human ventricular myocardium. J. Am. Coll. Cardiol. 36 (2000) 534-540
40. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J. Am. Coll. Cardiol. 38 (2001) 1644-1650